Literature DB >> 8295432

Airway dysfunction in patients with Parkinson's disease.

J L Izquierdo-Alonso1, F J Jiménez-Jiménez, F Cabrera-Valdivia, M Mansilla-Lesmes.   

Abstract

To investigate pulmonary function abnormalities in Parkinson's disease (PD), we obtained maximal inspiratory and expiratory flow-volume curves in 63 patients (59 under treatment) with different stages of the disease, not filtered for respiratory symptoms. PD severity was evaluated by the Unified PD Rating Scale, the Webster's scale, and Hoehn and Yahr staging. Patients with more severe PD had lower percentage forced vital capacity (FVC%), and peak inspiratory and expiratory flows. Those with fluctuations and/or dyskinesias had lower FVC% and percentage forced expiratory flow volume in 1 sec (FEV1%). There were a number of weak but significant correlations between PD scales and spirographic parameters. Thirty one patients (49.2%) had pathological flow-volume curves. The clinical profile and the duration of the disease did not influence the pattern of the curve. Physiologic evidence of upper airway obstruction was observed in 3 cases. A spirometric restrictive ventilatory defect (FEV1/FVC higher than or equal to 80%) was observed in 54 patients (85%), while generalized airway obstruction was present only in one nonsmoker. We conclude that abnormal flow-volume loop contour is a frequent finding in PD. This probably reflects involvement of the upper airway musculature, that in some patients can produce upper airway obstruction. Generalized airflow limitation is not an important characteristic of PD. By contrast, a restrictive spirometric defect, probably due to incoordinated expiratory effort or abnormally low chest wall compliance, is the main spirometric finding in these patients.

Entities:  

Mesh:

Year:  1994        PMID: 8295432     DOI: 10.1007/BF00186168

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  21 in total

Review 1.  Flow oscillations on the flow-volume loop: clinical and physiological implications.

Authors:  W G Vincken; M G Cosio
Journal:  Eur Respir J       Date:  1989-06       Impact factor: 16.671

2.  The maximal expiratory flow-volume curve. Normal standards, variability, and effects of age.

Authors:  R J Knudson; R C Slatin; M D Lebowitz; B Burrows
Journal:  Am Rev Respir Dis       Date:  1976-05

3.  Reversibility of upper airway obstruction after levodopa therapy in Parkinson's disease.

Authors:  W G Vincken; C M Darauay; M G Cosio
Journal:  Chest       Date:  1989-07       Impact factor: 9.410

4.  Pulmonary function in Parkinson's disease.

Authors:  A Hovestadt; J M Bogaard; J D Meerwaldt; F G van der Meché; J Stigt
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-03       Impact factor: 10.154

Review 5.  The flow-volume curve. A current perspective.

Authors:  R E Hyatt; L F Black
Journal:  Am Rev Respir Dis       Date:  1973-02

6.  A comparison of maximum inspiratory and expiratory flow in health and in lung disease.

Authors:  J Jordanoglou; N B Pride
Journal:  Thorax       Date:  1968-01       Impact factor: 9.139

7.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

8.  Obstructive respiratory dysfunction in parkinsonian patients.

Authors:  H C Neu; J J Connolly; F W Schwertley; H A Ladwig; A W Brody
Journal:  Am Rev Respir Dis       Date:  1967-01

9.  Multiple system atrophy with autonomic failure: clinical, histological and neurochemical observations on four cases.

Authors:  E G Spokes; R Bannister; D R Oppenheimer
Journal:  J Neurol Sci       Date:  1979-09       Impact factor: 3.181

10.  Flow oscillations on the flow-volume loop: a nonspecific indicator of upper airway dysfunction.

Authors:  W Vincken; M G Cosio
Journal:  Bull Eur Physiopathol Respir       Date:  1985 Nov-Dec
View more
  16 in total

1.  Respiratory-swallowing coordination and swallowing safety in patients with Parkinson's disease.

Authors:  Michelle S Troche; Irene Huebner; John C Rosenbek; Michael S Okun; Christine M Sapienza
Journal:  Dysphagia       Date:  2010-07-11       Impact factor: 3.438

2.  Primary laryngospasm in a patient with Parkinson's disease: treatment with CPAP via minitracheostomy following intubation.

Authors:  B F Fikkers; D F Zandstra
Journal:  Intensive Care Med       Date:  1995-10       Impact factor: 17.440

3.  The coordination of breathing and swallowing in Parkinson's disease.

Authors:  Roxann Diez Gross; Charles W Atwood; Sheryl B Ross; Kimberly A Eichhorn; Joan W Olszewski; Patrick J Doyle
Journal:  Dysphagia       Date:  2007-11-20       Impact factor: 3.438

4.  Research-based Updates in Swallowing and Communication Dysfunction in Parkinson Disease: Implications for Evaluation and Management.

Authors:  C K Broadfoot; D Abur; J D Hoffmeister; C E Stepp; M R Ciucci
Journal:  Perspect ASHA Spec Interest Groups       Date:  2019-10-11

Review 5.  Ventilatory Dysfunction in Parkinson's Disease.

Authors:  Guillaume Baille; Anna Maria De Jesus; Thierry Perez; David Devos; Kathy Dujardin; Christelle Monaca Charley; Luc Defebvre; Caroline Moreau
Journal:  J Parkinsons Dis       Date:  2016-06-16       Impact factor: 5.568

6.  Early occurrence of inspiratory muscle weakness in Parkinson's disease.

Authors:  Guillaume Baille; Thierry Perez; David Devos; Valérie Deken; Luc Defebvre; Caroline Moreau
Journal:  PLoS One       Date:  2018-01-12       Impact factor: 3.240

7.  Arytenoid cartilage movements are hypokinetic in Parkinson's disease: A quantitative dynamic computerised tomographic study.

Authors:  Laura Perju-Dumbrava; Ken Lau; Debbie Phyland; Vicki Papanikolaou; Paul Finlay; Richard Beare; Philip Bardin; Stephen Stuckey; Peter Kempster; Dominic Thyagarajan
Journal:  PLoS One       Date:  2017-11-03       Impact factor: 3.240

8.  Impact of Progression of Parkinson's Disease and Various Other Factors on Generalized Anxiety Disorder.

Authors:  Abdul Qayyum Rana; Hamza Ansari; Abdul Rehman M Qureshi; Eraad Rahman
Journal:  J Neurosci Rural Pract       Date:  2018 Jul-Sep

Review 9.  Respiratory Function and Dysfunction in Parkinson-Type Neurodegeneration.

Authors:  M Pokusa; D Hajduchova; T Buday; A Kralova Trancikova
Journal:  Physiol Res       Date:  2020-03-27       Impact factor: 1.881

Review 10.  Respiratory Dysfunctions in Parkinson's Disease Patients.

Authors:  Any Docu Axelerad; Alina Zorina Stroe; Oana Cristina Arghir; Daniel Docu Axelerad; Anca Elena Gogu
Journal:  Brain Sci       Date:  2021-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.